🇺🇸

US SEC Filing Intelligence

· daily

US Merger & Acquisition SEC Filings — May 19, 2026

The May 19, 2026, US M&A filing stream reveals a market bifurcated between high-conviction, well-capitalized take-privates and a flurry of SPAC deadline extensions signaling execution risk. The most material event is the $3.1B take-private of Mister Car Wash by Leonard Green & Partners, a definitive bullish signal for the sector that validates asset values. Conversely, the SPAC landscape shows systemic strain: three separate SPACs (Plum, Bayview, EagleRock) disclosed deadline extensions, with Bayview's fourth amendment pushing its closing date over 2.5 years from the original agreement, indicating severe deal fatigue. A major capital markets event was EagleRock Land's $286.6M IPO, a rare positive signal for the Permian Basin asset class. Insider activity was notably absent across the stream, with only one director resignation (Valuence Merger Corp.) that was non-disputative, providing no conviction signals. Forward-looking data points to a catalyst-rich June, with Exascale Labs' COMPUTEX Taipei exhibition and Eton's IMPAVIDO launch in September creating specific alpha opportunities. The aggregate trend shows capital rotating away from SPAC structures toward direct listings and take-privates, with the Mister Car Wash deal demonstrating the premium available for quality assets in a rate-stabilizing environment.

10 high priority 10 total filings
· monthly

US Pre-Market SEC Filings Roundup — May 19, 2026

Overnight filings reveal a market bifurcated between robust operational execution in infrastructure and energy transition versus acute distress in small-cap and commodity-exposed names. Home Depot's mixed quarter, with top-line growth but margin compression, sets a cautious tone for consumer spending, while Eagle Materials' record revenue but declining earnings highlights the 'growth without profit' theme in materials. The most significant corporate actions are the $2.2B acquisition of LiveRamp by Publicis and the $1.35B de-SPAC for Einride, signaling strong M&A appetite in data and green tech. However, a cluster of distressed signals—including Novelis's $84M loss from plant fires, TechPrecision's liquidity crunch, and Natural Alternatives' near-zero gross margin—demand immediate risk review. Insider activity is muted, but the conversion of GitLab's chair from supervoting to common stock is a notable governance event. The forward-looking calendar is packed with catalysts, including Thermon's merger vote, Immunic's Phase 3 readout, and multiple SPAC deadlines, offering both event-driven and turnaround opportunities.

22 high priority 28 medium 50 total filings
· daily

Federal Construction & Infrastructure Contracts — May 18, 2026

The single contract analyzed, a $605M firm-fixed-price delivery order from DHS/CBP to Fisher Sand & Gravel for border wall construction in San Diego, represents a purely civilian infrastructure award with no defense exposure. The aggregate obligation of $605M is concentrated in a single private entity, limiting direct public equity impact but signaling sustained government investment in border security infrastructure. The highest-conviction signal is neutral, given the private recipient and high cost-overrun risk under a firm-fixed-price structure. Key risks include potential political shifts affecting border wall appropriations and execution risk for the contractor, which may indirectly affect publicly traded subcontractors or material suppliers.

1 total filings
· daily

DHS Homeland Security Contracts — May 18, 2026

This digest covers a single $605 million DHS/CBP contract awarded to privately held Fisher Sand & Gravel for border wall construction in San Diego (2026-2028). The award is entirely civilian (DHS), with no defense-related exposure, and carries a neutral signal strength of 5/10. The highest-conviction signal is the sustained government investment in border infrastructure, but the private nature of the recipient limits direct public equity impact. Key risks include execution risk under a firm-fixed-price structure and potential political volatility around border wall appropriations. Investors should watch for any publicly traded subcontractors or material suppliers that may benefit indirectly.

1 total filings
· daily

New Federal Contractors — May 18, 2026

The single contract analyzed, a $605M firm-fixed-price delivery order from DHS/CBP to private firm Fisher Sand & Gravel for border wall construction in San Diego, represents the entirety of the period's activity. This is a purely civilian award with no defense-related content, signaling sustained government investment in border infrastructure. The neutral signal strength (5/10) and lack of public equity exposure limit direct investment implications, but the contract's size and fixed-price structure create high execution risk for the private contractor. Key risks include political shifts in border policy and potential cost overruns, while opportunities lie in monitoring subcontractor disclosures for indirect public equity exposure.

1 total filings
· daily

Significant Contract Modifications ($10M+) — May 18, 2026

The two contracts analyzed represent $605.6 million in total obligations, both from civilian agencies (DHS and HHS), with zero defense-related awards. The dominant theme is a massive $605 million border wall construction contract awarded to private firm Fisher Sand & Gravel by DHS/CBP, signaling sustained government investment in border infrastructure despite political risks. The second contract, a $542,604 sterile water supply deal with Pfizer, is immaterial to the company's revenue. The highest-conviction signal is the border wall award's potential to benefit publicly traded subcontractors or material suppliers, though direct public equity exposure is absent. Key risks include execution risk under a fixed-price contract and political vulnerability of border wall funding to policy shifts.

2 total filings
· daily

Contract Option Exercises — May 18, 2026

The two contracts awarded on May 15, 2026, total $605.6 million in obligations, with zero defense-related awards — both are civilian agency contracts (DHS and HHS), highlighting a bifurcated government spending pattern. The dominant signal is a $605 million DHS/CBP border wall construction award to private firm Fisher Sand & Gravel, which, while not directly investable, signals sustained infrastructure spending that could benefit publicly traded subcontractors or material suppliers. The second award, a $542,604 HHS/ASPR sterile water contract to Pfizer, is immaterial to the company's $60B+ revenue base. The highest-conviction signal is the border wall contract's full competition after exclusion of sources, which introduces execution and political risk. Key watch items include potential subcontractor disclosures from Fisher Sand & Gravel and DHS budget appropriations for border security.

2 total filings
· daily

Mega Contracts Monitor ($100M+) — May 18, 2026

The single mega-contract in this period is a $605M firm-fixed-price delivery order from DHS/CBP to privately held Fisher Sand & Gravel for border wall construction in San Diego. This is a purely civilian award with no defense exposure, signaling sustained government investment in border infrastructure under a full-and-open competition structure. The neutral signal strength (5/10) and lack of public equity direct exposure limit immediate investment implications, but the contract's size and fixed-price risk profile warrant monitoring for subcontractor or material supplier disclosures. Key risks include execution cost overruns on the fixed-price contract and potential budget or policy shifts affecting border wall appropriations.

1 total filings
· daily

High-Value Federal Grants ($5M+) — May 18, 2026

The single high-value grant analyzed for May 18, 2026, is a $605M firm-fixed-price delivery order from the Department of Homeland Security (DHS/CBP) to privately held Fisher Sand & Gravel for border wall construction in San Diego. This is a civilian contract with no direct defense exposure, and the neutral signal strength (5/10) reflects the lack of publicly traded prime exposure. The award underscores sustained government investment in border infrastructure, but execution risk is high given the fixed-price nature and political sensitivity. Key watch items include potential subcontractor disclosures and DHS budget appropriations for border security.

1 total filings
· daily

General Federal Contracts — May 18, 2026

This single-contract digest reveals a $605M civilian award from the Department of Homeland Security (DHS) to Fisher Sand & Gravel for border wall construction in San Diego, representing 100% of the period's total obligation. The contract is entirely civilian (0% defense-related) and carries a neutral signal strength of 5/10, reflecting the lack of direct public equity exposure due to the recipient's private status. The highest-conviction signal is the sustained government investment in border infrastructure, which may indirectly benefit publicly traded material suppliers or subcontractors. Key risks include execution risk from the firm-fixed-price structure and potential political volatility around border wall funding, particularly under a continuing resolution scenario.

1 total filings
· daily

S&P 500 Technology Sector SEC Filings — May 18, 2026

The 17 filings reveal a mixed landscape within the S&P 500 Technology sector and broader market. Key themes include significant insider buying at Genco Shipping, a large jury verdict against Acadia Healthcare, and a forward stock split for the abrdn Palladium ETF. Period-over-period trends show Genco's dramatic turnaround to profitability, while Madison Technologies remains revenue-less with worsening cash burn. Insider activity is sparse but notable at Genco, where management is actively opposing a tender offer. Capital allocation varies, with Genco increasing dividends and Cottonwood raising preferred equity. Forward-looking data highlights upcoming catalysts such as ImmunityBio's FDA engagement for BCG approval and RideNow's potential credit facility expansion. Overall, the digest points to selective opportunities in shipping and biotech, while caution is warranted for cash-burning microcaps and litigation risks.

6 high priority 11 medium 17 total filings
· daily

Nasdaq 100 Stocks SEC Filings — May 18, 2026

The 18 filings reveal a bifurcated landscape: while Genco Shipping & Trading and CoStar Group show strong operational turnarounds and proactive capital allocation, several biotech and cash-burning companies (Estrella Immunopharma, Madison Technologies) face liquidity pressures. Period-over-period comparisons highlight Genco's net income swing of +$21.2M YoY and CoStar's $1.5B buyback authorization, contrasting with Estrella's 28.5% G&A surge and Madison's zero revenue. Insider activity is limited but notable: Genco's CEO actively defends against a tender offer, while Acadia Healthcare faces a $105M adverse verdict. Forward-looking catalysts include MetaVia's ADA abstracts and ImmunityBio's BCG approval path. Sector themes center on capital discipline (shipping, real estate) versus speculative biotech spending, with a cautious tech hedge evidenced by Arkadios Wealth Advisors' large QQQ put positions.

5 high priority 13 medium 18 total filings
· daily

S&P 500 Financials Sector SEC Filings — May 18, 2026

The May 18, 2026 batch of 50 S&P 500 Financials filings reveals a sector bifurcated between large-cap stability and small/mid-cap distress. The most significant event is the $2.5B all-cash acquisition of LiveRamp by Publicis Groupe at a 30% premium, signaling strong M&A appetite for data assets. However, this is overshadowed by severe distress signals: Bitcoin Depot has entered bankruptcy proceedings, and Gossamer Bio is executing a coercive debt-for-equity swap requiring 98% participation. Period-over-period trends show a mixed picture: LiveRamp's 9% YoY revenue growth and 107% net retention contrast sharply with iSpecimen's 85% revenue collapse and OLB Group's 29% decline. Insider activity is notably absent across most filings, but management actions—such as Wyndham's CEO disclosing a cancer diagnosis while reaffirming guidance—provide nuanced signals. Capital allocation trends are defensive: Coeur Mining has aggressively repurchased $69.7M of stock, while Presidio Property Trust is cutting debt and CEO pay. The overarching theme is capital preservation and strategic repositioning, with M&A and restructuring dominating the narrative over organic growth.

22 high priority 28 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — May 18, 2026

The 50 filings for the S&P 500 Consumer Staples stream reveal a sector in transition, with significant capital allocation shifts, governance battles, and a few high-growth outliers. While the majority of filings are procedural (annual meeting results, proxy statements), several high-materiality events stand out. **Altria Group** faces a high-risk director departure, while **CoStar Group** is undertaking a major governance and capital allocation overhaul in response to activist pressure, including a $1.5B buyback. **CleanCore Solutions** presents a significant red flag with a material restatement and internal control weakness, contrasting with **Koil Energy Solutions** which reported record revenue and a return to profitability. **Claritev Corp** disclosed a DOJ antitrust probe, adding regulatory risk. The most actionable themes are the push for shareholder-friendly capital returns (CoStar, CCEP) and the severe financial reporting issues at CleanCore, which serve as a cautionary tale for micro-cap investors. Overall, the sector shows a mix of stable, cash-generating businesses returning capital and smaller players facing existential challenges.

16 high priority 34 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — May 18, 2026

The 50 filings from the S&P 500 Industrials stream reveal a sector bifurcated between robust growth in niche areas (e.g., shipping, medical devices) and significant financial distress in others (e.g., Bitcoin Depot's Bitcoin Depot's bankruptcy, Banzai's dilution). Period-over-period data shows strong revenue growth at Bally's (+28.3% YoY) and Genco Shipping (swinging to a $9.3M profit from an $11.9M loss), but also highlights margin compression and cash burn at several firms. Insider activity is limited, but the heavy insider-related financing at Yale Transaction Finders and the departure of FedEx's CAO are notable. Capital allocation trends are mixed, with Bally's refinancing debt and Genco raising dividends, while others like Tofutti Brands and ABVC Biopharma face severe cash constraints. The most critical developments include Bitcoin Depot's bankruptcy, Bally's major project advancements, and the FedEx Freight spin-off, which together signal a 'survival of the fittest' dynamic in the industrials space.

24 high priority 26 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — May 18, 2026

The three filings for the S&P 500 Energy stream on May 18, 2026, represent a very quiet session with no direct energy sector activity. The primary developments are procedural steps in XOMA Royalty Corp's merger with Ligand Pharmaceuticals, involving a holding company reorganization that does not alter economic terms. Chesapeake Wealth Management's 13F filing provides a snapshot of a diversified portfolio with no energy-specific concentration. No period-over-period comparisons, insider trading, forward-looking guidance, or capital allocation changes were present in any of the filings, limiting actionable insights. The absence of energy sector filings and the lack of enriched data trends (e.g., revenue growth, margin changes) indicate a lull in sector activity. Investors should monitor for upcoming earnings calls and regulatory decisions from major energy companies to identify future catalysts.

1 high priority 2 medium 3 total filings
· daily

US Material Events SEC 8-K Filings — May 18, 2026

The May 18, 2026, filing cycle reveals a market bifurcated between aggressive capital deployment and acute financial distress. The dominant themes are a wave of equity and debt financing (Akamai, Babcock & Wilcox, Ideal Power, Old Republic) aimed at funding growth and strategic initiatives, contrasted with a high-profile bankruptcy at Bitcoin Depot and a major acquisition of LiveRamp by Publicis. Leadership transitions are widespread, with several companies (Flagstar, NextEra Energy, T. Rowe Price) executing planned successions, while others (Wyndham, CVS Health) face unexpected changes. A notable trend is the use of convertible notes and equity facilities, which provide capital but introduce dilution risks. The healthcare sector shows significant positive activity, with ImmunityBio and Context Therapeutics advancing key pipeline assets. Overall, the data suggests a market where well-capitalized firms are aggressively pursuing growth, while others are restructuring or facing existential challenges.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — May 18, 2026

The May 18, 2026 batch of 50 filings from the Dow 30 universe reveals a market bifurcated between aggressive capital deployment and operational strain. A dominant theme is the use of equity-linked financing and M&A to fund growth, with notable examples including LiveRamp's $2.5B all-cash acquisition by Publicis Groupe at a 30% premium, Bally's $4.0B Bronx development and $1.1B refinancing, and Soluna's $53M wind farm acquisition. However, this expansion is occurring against a backdrop of widening losses and cash burn for many companies, as seen in Soluna's net loss doubling to $17.9M and ABVC Biopharma's 79% loss increase with zero revenue. Insider activity is sparse but notable, with director resignations at Innoviva and significant shareholder dissent on pay at Nicolet Bankshares (32.7% against). Capital allocation is mixed: while some firms like Virgin Galactic are using stock to pay down debt, others like Babcock & Wilcox are raising $200M via dilutive offerings. The forward-looking calendar is rich with catalysts, including the July 6, 2026 Clough fund meetings and the May 19, 2026 NBT Bancorp annual meeting, but also carries risks from pending regulatory approvals (CFIUS on LiveRamp) and ongoing Nasdaq compliance issues (Faraday Future). Overall, the data suggests a market where strategic bets are being placed, but the financial health of the underlying companies requires close scrutiny of cash flow and margin trends.

29 high priority 21 medium 50 total filings
· daily

US SEC Filings Daily Market Digest — May 18, 2026

Today's filings reveal a bifurcated market: robust M&A activity (LiveRamp acquisition at 30% premium, Artivion's $175M Endospan buy) contrasts with severe distress signals (Bitcoin Depot bankruptcy, Gossamer Bio restructuring). Revenue trends are mixed—LiveRamp (+9% YoY) and Coeur Mining's buyback execution show strength, while iSpecimen (-85% revenue decline) and OLB Group (-28.6%) highlight micro-cap fragility. Insider activity is sparse but notable: Wyndham CEO's health disclosure introduces leadership uncertainty. Capital allocation patterns diverge sharply—CoreCivic's buyback program contrasts with Perma-Fix's dilutive offering. Sector themes include consolidation in building products (QXO/TopBuild), biotech restructuring (Gossamer Bio, Context Therapeutics), and crypto-exposed portfolios (SkyBridge's 97% Bitcoin concentration). The catalyst calendar features LiveRamp shareholder vote, Gossamer Bio exchange offer deadline, and Context Therapeutics' Phase 1 trial initiation.

22 high priority 28 medium 50 total filings